A Placebo Controlled Safety and Efficacy Study of MSDC-0160 in Type 2 Diabetes With Active Comparator

Completed · Phase 2 · Has a placebo group

Conditions studied: Type 2 Diabetes Mellitus

In brief

The purpose of this study is to determine if MSDC-0160 is effective in the treatment of Type 2 diabetes.

Key facts

Study ID

NCT00760578

Run by

Metabolic Solutions Development Company

People needed

86

Starts

2008-09-01

Expected to finish

2009-02-01

Last updated by the study team

2013-05-03

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of Type 2 Diabetes naive or on metformin
• Male and female (postmenopausal or surgically sterilized), 18 to 70 years of age.

You may not qualify if…

• Use of diabetes medications other than metformin.
• History of heart failure or previous myocardial infarction.
• Blood pressure great than 160/100 mmHg.

Where it is running

• Study site — Los Angeles, California, United States
• Study site — Miami Gardens, Florida, United States
• Study site — West Palm Beach, Florida, United States
• Study site — Kalamazoo, Michigan, United States
• Study site — Greenville, South Carolina, United States
• Study site — Dallas, Texas, United States
• Study site — San Antonio, Texas, United States
• Study site — Renton, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.